April Phantana-angkool, MD

April Phantana-angkool, MD

Accepting new patients
Specializes in: Breast Surgery
Female | Speaks English, Thai
Phone: 425.688.0212

Clinical Expertise

Services & Programs

  • Breast surgery
  • Breast surgical oncology

Clinical Interests

My clinical interests include treating all breast conditions ranging from benign to malignant disease in both women and men. I specialize in breast surgical oncology and offer surgical treatment options, including breast conservation surgery, nipple and skin sparing mastectomy, sentinel lymph node biopsy, and oncoplastic surgery. I utilize a multidisciplinary approach, which includes a team of physicians from medical oncology, radiation oncology, reconstructive plastic surgery, radiology, pathology and genetics. This allows us to provide individualized treatment options to address patient specific needs. I also have a focus on the evaluation and treatment of patients with hereditary breast cancer as well as those with a high-risk of developing breast cancer in the future.

Education and Training

Medical School

  • University of Alabama School of Medicine 


  • Baptist Health System


  • Baptist Health System


  • Levine Cancer Institute at Carolinas Medical Center - Breast Surgical Oncology

Honors, Achievements & Memberships

Board Certification

  • American Board of Surgery - General Surgery


  • Society of Surgical Oncology
  • American Society of Breast Surgeons
  • American College of Surgeons


  • Phantana-angkool A, Forster MR Warren YE, Livasy CA, Sobel AH, Beasley LM, Trufan SJ, Hadzikadic-Gusic L, Sarantou T, Voci AE, Sarma D, White RL Jr. Rate of radial scars by core biopsy and upgrading to malignancy or high-risk lesions before and after introduction of digital breast tomosynthesis. Breast Cancer Research and Treatment. 2019 Jan;173(1):23-29.
  • Phantana-angkool A, Voci AE, Warren YE, Livasy CA, Beasley LM, Robinson MM, Hadzikadic-Gusic L, Sarantou T, Forster MR, Sarma D, White RL Jr. Ductal carcinoma in situ with microinvasion on core biopsy: evaluating tumor upstaging rate, lymph node metastasis rate, and associated predictive variables. Annals of Surgical Oncology. 2019 Nov;26(12):3874-3882.